Shahzad Affan Mahmood, Lu Wenying, Dey Surajit, Bhattarai Prem, Gaikwad Archana Vijay, Jaffar Jade, Westall Glen, Sutherland Darren, Singhera Gurpreet Kaur, Hackett Tillie-Louise, Eapen Mathew Suji, Sohal Sukhwinder Singh
Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS 7248, Australia.
Medical School, Oceania University of Medicine, Apia WS1330, Samoa.
J Clin Med. 2024 Apr 6;13(7):2126. doi: 10.3390/jcm13072126.
: Idiopathic pulmonary fibrosis (IPF) is an irreversible lung fibrotic disorder of unknown cause. It has been reported that bacterial and viral co-infections exacerbate disease pathogenesis. These pathogens use adhesion molecules such as platelet activating factor receptor (PAFR) and intercellular adhesion molecule-1 (ICAM-1) to gain cellular entry, causing infections. : Immunohistochemical staining was carried out for lung resections from IPF patients (n = 11) and normal controls (n = 12). The quantification of PAFR and ICAM-1 expression is presented as a percentage in the small airway epithelium. Also, type 2 pneumocytes and alveolar macrophages were counted as cells per mm of the parenchymal area and presented as a percentage. All image analysis was done using Image Pro Plus 7.0 software. : PAFR expression significantly increased in the small airway epithelium ( < 0.0001), type 2 pneumocytes ( < 0.0001) and alveolar macrophages ( < 0.0001) compared to normal controls. Similar trend was observed for ICAM-1 expression in the small airway epithelium ( < 0.0001), type 2 pneumocytes ( < 0.0001) and alveolar macrophages ( < 0.0001) compared to normal controls. Furthermore, the proportion of positively expressed type 2 pneumocytes and alveolar macrophages was higher in IPF than in normal control. : This is the first study to show PAFR and ICAM-1 expression in small airway epithelium, type 2 pneumocytes and alveolar macrophages in IPF. These findings could help intervene microbial impact and facilitate management of disease pathogenesis.
特发性肺纤维化(IPF)是一种病因不明的不可逆性肺纤维化疾病。据报道,细菌和病毒合并感染会加剧疾病的发病机制。这些病原体利用血小板活化因子受体(PAFR)和细胞间黏附分子-1(ICAM-1)等黏附分子进入细胞,从而引发感染。
对11例IPF患者和12例正常对照者的肺切除标本进行免疫组织化学染色。PAFR和ICAM-1表达的定量以小气道上皮中的百分比表示。此外,Ⅱ型肺泡上皮细胞和肺泡巨噬细胞按每平方毫米实质区域的细胞数进行计数,并以百分比表示。所有图像分析均使用Image Pro Plus 7.0软件完成。
与正常对照相比,PAFR在小气道上皮(P<0.0001)、Ⅱ型肺泡上皮细胞(P<0.0001)和肺泡巨噬细胞(P<0.0001)中的表达显著增加。与正常对照相比,ICAM-1在小气道上皮(P<0.0001)、Ⅱ型肺泡上皮细胞(P<0.0001)和肺泡巨噬细胞(P<0.0001)中的表达也呈现相似趋势。此外,IPF中Ⅱ型肺泡上皮细胞和肺泡巨噬细胞阳性表达的比例高于正常对照。
这是首次在IPF的小气道上皮、Ⅱ型肺泡上皮细胞和肺泡巨噬细胞中显示PAFR和ICAM-1表达的研究。这些发现有助于干预微生物的影响并促进疾病发病机制的管理。